SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-123941
Filing Date
2016-05-27
Accepted
2016-05-27 14:12:59
Documents
1
Period of Report
2016-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3919
  Complete submission text file 0001209191-16-123941.txt   5488
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Issuer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 6035 STONERIDGE DRIVE PLEASANTON CA 94588
Business Address
Smith David V (Reporting) CIK: 0001229447 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 161681672